Trident Texofab Balance Sheet Health
Financial Health criteria checks 2/6
Trident Texofab has a total shareholder equity of ₹158.0M and total debt of ₹406.2M, which brings its debt-to-equity ratio to 257.1%. Its total assets and total liabilities are ₹843.9M and ₹685.9M respectively. Trident Texofab's EBIT is ₹53.8M making its interest coverage ratio 0.9. It has cash and short-term investments of ₹504.0K.
Key information
257.1%
Debt to equity ratio
₹406.22m
Debt
Interest coverage ratio | 0.9x |
Cash | ₹504.00k |
Equity | ₹158.03m |
Total liabilities | ₹685.91m |
Total assets | ₹843.93m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 540726's short term assets (₹537.3M) exceed its short term liabilities (₹456.5M).
Long Term Liabilities: 540726's short term assets (₹537.3M) exceed its long term liabilities (₹229.4M).
Debt to Equity History and Analysis
Debt Level: 540726's net debt to equity ratio (256.7%) is considered high.
Reducing Debt: 540726's debt to equity ratio has increased from 99.4% to 257.1% over the past 5 years.
Debt Coverage: 540726's debt is not well covered by operating cash flow (6.5%).
Interest Coverage: 540726's interest payments on its debt are not well covered by EBIT (0.9x coverage).